Brent Pfeiffenberger serves as President and CEO of Century Therapeutics, Inc. (IPSC). Pfeiffenberger has also held reporting roles at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Pfeiffenberger has reported 14 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Brent Pfeiffenberger has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Century Therapeutics, Inc. (IPSC)3 filingsUpdated Aug 30, 2026
Brent Pfeiffenberger is President and CEO, Director of Century Therapeutics, Inc. (IPSC). 15 SEC Form 4 filings on record going back to 2024, most recently on 18 August 2026. Most recent open-market trade: bought $30K of IPSC on 16 December 2025. Lifetime open-market purchases: $48K. Lifetime open-market sales: $15K.
Every recent SEC Form 4 transaction Brent Pfeiffenberger has reported, most recent first.
InsiderAlpha's records for Brent Pfeiffenberger go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. The typical open-market purchase is $24K (2 buys totaling $48K). The largest single buy on record is $30K of IPSC in 2025. Sales side: 2 recorded sales totaling $15K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Brent Pfeiffenberger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Brent Pfeiffenberger is a corporate insider, tracked as President and CEO, Director of Century Therapeutics, Inc. (IPSC). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($48K) and 2 open-market sales ($15K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$IPSC Century Therapeutics, Inc.463 shares @ $2.13$986